CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Buspirone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02674412
NCT02674412N/ACompleted

Placebo-controlled, Randomized, Double-blind, Cross-over Style Trial of Buspirone in Functional Dysphagia

The Cleveland Clinic·interventional·Posted Feb 4, 2016·Updated Aug 10, 2018

In Brief

A clinical study evaluating Buspirone and Placebo for Functional Dysphagia and Ineffective Esophageal Motility. Completed, enrolled 10 participants.

Detailed Summary

This study evaluates the utility of buspirone in patients who have a diagnosis of functional dysphagia. All participants will be randomized to receive either a placebo pill or buspirone. Subsequently, we will evaluate whether their swallowing is improved. Participants who were randomized to receive placebo will then receive buspirone and those who were receiving buspirone will receive placebo. We will again evaluate whether their swallowing improved.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 4, 2016
Enrollment StartFeb 1, 2016
Primary CompletionApr 12, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.4 years ago

Interventions

Buspironedrug

Placebodrug

Placebo Pill Manufactured by the Investigational Pharmacy at Cleveland Clinic